These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study. Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Åblad B, Bussadori CM, Glaus T, Kovačević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir A, Lynne O'Sullivan M, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R. J Vet Intern Med; 2013 Feb; 27(6):1441-51. PubMed ID: 24010489 [Abstract] [Full Text] [Related]
9. Hemodynamic effects of benazepril, an angiotensin-converting enzyme inhibitor, as studied in conscious normotensive dogs. Ishibashi T, Tatebe S, Mitomi A, Tanaka M, Imai S. Cardiovasc Drugs Ther; 1991 Jun; 5(3):635-41. PubMed ID: 1652276 [Abstract] [Full Text] [Related]
10. Bioequivalence of a new liquid formulation of benazepril compared with the reference tablet product. Kelers K, Devi JL, Anderson GA, Zahra P, Vine JH, Whittem T. Aust Vet J; 2013 Aug; 91(8):312-9. PubMed ID: 23889096 [Abstract] [Full Text] [Related]
11. Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs. Mochel JP, Fink M, Peyrou M, Soubret A, Giraudel JM, Danhof M. Pharm Res; 2015 Jun; 32(6):1931-46. PubMed ID: 25446774 [Abstract] [Full Text] [Related]
12. Attenuation of the blood pressure response to exogenous angiotensin I after oral administration of benazepril to healthy adult horses. Afonso T, Giguère S, Rapoport G, Brown SA, Coleman AE. Equine Vet J; 2017 May; 49(3):358-362. PubMed ID: 27224673 [Abstract] [Full Text] [Related]
13. Safety of a benazepril and pimobendan combination tablet in adult healthy dogs. Kuntz EA, Strehlau G, Giraudel JM, King JN. J Vet Pharmacol Ther; 2018 Feb; 41(1):105-116. PubMed ID: 28649790 [Abstract] [Full Text] [Related]
14. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure. Häggström J, Lord PF, Höglund K, Ljungvall I, Jöns O, Kvart C, Hansson K. J Vet Intern Med; 2013 Feb; 27(6):1452-62. PubMed ID: 24128373 [Abstract] [Full Text] [Related]
15. Long-term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy. Vollmar AC, Fox PR. J Vet Intern Med; 2016 Feb; 30(2):553-9. PubMed ID: 26936799 [Abstract] [Full Text] [Related]
16. Plasma angiotensin converting enzyme activity and pharmacokinetics of benazepril and benazeprilat in cats after single and repeated oral administration of benazepril.HCl. King JN, Humbert-Droz E, Maurer M. J Vet Pharmacol Ther; 1999 Dec; 22(6):360-7. PubMed ID: 10651464 [Abstract] [Full Text] [Related]
19. Capturing the dynamics of systemic Renin-Angiotensin-Aldosterone System (RAAS) peptides heightens the understanding of the effect of benazepril in dogs. Mochel JP, Peyrou M, Fink M, Strehlau G, Mohamed R, Giraudel JM, Ploeger B, Danhof M. J Vet Pharmacol Ther; 2013 Apr; 36(2):174-80. PubMed ID: 22568394 [Abstract] [Full Text] [Related]